DeepMed Research

Haleon

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Public

Established: 2022-01-01

Employees: 25.4K

Market Cap: -

Website: http://www.haleon.com

Introduction: Haleon Plc engages in the provision of personal healthcare products. The firm focuses on consumer healthcare. It operates under the following geographical segments: North America, EMEA and LatAm, and Asia Pacific. The company was founded on July 18, 2022 and is headquartered in Weybridge, the United Kingdom.

Clinical Trials

A Clinical Study to Evaluate the Efficacy of a Stannous Fluoride Toothpaste for the Relief of Dentine Hypersensitivity in a Chinese Population

Not Applicable

Completed

Conditions: Dentin Sensitivity

Interventions: Drug: Sensodyne Sensitivity & Gum
Drug: Crest Cavity Protection Fresh Lime
Drug: Sensodyne Repair and Protect

First Posted Date: 2023-03-02

Last Posted Date: 2024-11-20

Lead Sponsor: HALEON

Target Recruit Count: 416

Registration Number: NCT05750745

Locations: 🇨🇳
Department of Preventive Dentistry, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

A Bioequivalence Study of Two Ibuprofen Arginine Granules 400 mg Formulations Under Fasting and Fed Conditions in Chinese Healthy Adult Subjects

Phase 1

Completed

Conditions: Pain

Interventions: Drug: Ibuprofen arginine granules 400 mg
Drug: Ibuprofen arginine granules 400 mg (Spedifen)

First Posted Date: 2023-02-21

Last Posted Date: 2023-05-31

Lead Sponsor: HALEON

Target Recruit Count: 84

Registration Number: NCT05737069

Locations: 🇨🇳
Clinical Pharmacological Research Center, Wenjiang, Chengdu, China

A Bioequivalence Study of Advil PM Liqui-Gels Minis (Ibuprofen/Diphenhydramine Hydrochloride 200 mg/25 mg) Compared to the Current Marketed Advil PM Liqui-Gels (Ibuprofen/Diphenhydramine Hydrochloride 200 mg/25 mg) in Healthy Adult Subjects Under Fasted Conditions

Phase 1

Completed

Conditions: Pain

Interventions: Drug: Advil PM Liqui-Gels
Drug: Advil PM Liqui-Gels Minis

First Posted Date: 2023-01-06

Last Posted Date: 2024-08-23

Lead Sponsor: HALEON

Target Recruit Count: 77

Registration Number: NCT05674721

Locations: 🇺🇸
Syneos Health, Miami, Florida, United States

A Clinical Study Investigating the Effects of a Dentifrice Containing 67% Sodium Bicarbonate When Used Twice Daily for 12 Weeks on Gingivitis Treatment and Plaque Removal

Not Applicable

Completed

Conditions: Gingivitis
Dental Plaque

Interventions: Drug: Colgate Cavity Protection Dentifrice
Drug: Corsodyl Original Dentifrice

First Posted Date: 2022-12-16

Last Posted Date: 2025-01-13

Lead Sponsor: HALEON

Target Recruit Count: 197

Registration Number: NCT05654662

Locations: 🇬🇧
University of Bristol, Bristol Dental School and Hospital, Bristol, United Kingdom

Otrivine: Quality of Life (QoL) Impact in a Real-World Setting

Phase 4

Completed

Conditions: Common Cold

Interventions: Drug: Otrivine Congestion Relief

First Posted Date: 2022-09-27

Last Posted Date: 2024-05-17

Lead Sponsor: HALEON

Target Recruit Count: 136

Registration Number: NCT05556148

Locations: 🇬🇧
The VCTC, Swadlincote, Derbyshire, United Kingdom

A Clinical Study to Examine the Effects of an Experimental Toothpaste Compared to a Regular Fluoride Toothpaste on Breath Odor in a Population With Gingivitis

Not Applicable

Completed

Conditions: Halitosis

Interventions: Other: Experimental Dentifrice
Other: Reference Dentifrice

First Posted Date: 2022-09-01

Last Posted Date: 2024-08-26

Lead Sponsor: HALEON

Target Recruit Count: 104

Registration Number: NCT05524948

Locations: 🇺🇸
Salus Research Inc., Fort Wayne, Indiana, United States

Clinical Study to Investigate the Tooth Stain Removal Efficacy of Two Experimental Toothpastes Compared to a Standard Toothpaste When Used Twice Daily for 8 Weeks

Not Applicable

Completed

Conditions: Oral Hygiene

Interventions: Drug: Experimental Dentifrice 2
Drug: Experimental Dentifrice 1
Drug: Reference Dentifrice

First Posted Date: 2022-07-15

Last Posted Date: 2024-04-12

Lead Sponsor: HALEON

Target Recruit Count: 280

Registration Number: NCT05459558

Locations: 🇺🇸
All Sum Research Center (c/o Family & Cosmetic Dentistry), Melbourne, Florida, United States

Bioequivalence Study of Esomeprazole 20 Milligram (mg) Delayed-Release Capsules in Healthy Adult Participants

Phase 1

Completed

Conditions: Gastrointestinal Diseases

Interventions: Drug: Esomeprazole 20 mg Delayed-Release Capsules
Drug: Esomeprazole 20 mg Delayed-Release Capsules (Nexium 24HR)

First Posted Date: 2022-03-03

Last Posted Date: 2024-02-05

Lead Sponsor: HALEON

Target Recruit Count: 61

Registration Number: NCT05265247

Locations: 🇨🇦
Syneos health, Québec, Canada

Exploratory Clinical Study to Investigate the Ability of an Experimental Combination Dentifrice to Protect Sensitive Teeth

Not Applicable

Completed

Conditions: Dentin Sensitivity

Interventions: Other: 3% PVM/MA + 5% KNO3 Combination
Other: 5% KNO3 Only
Other: 3% PVM/MA only
Other: Regular Fluoride

First Posted Date: 2022-02-17

Last Posted Date: 2022-10-18

Lead Sponsor: HALEON

Target Recruit Count: 120

Registration Number: NCT05243745

Locations: 🇬🇧
Bristol Dental School, University of Bristol, Bristol, United Kingdom

A Clinical Study to Evaluate the Maximum Maxillary Bite Force (BF) When Using Two Novel Denture Adhesives Compared to Using No-Adhesive

Phase 3

Completed

Conditions: Denture Retention

Interventions: Device: Experimental Denture Adhesive 2
Device: Experimental Denture Adhesive 1
Device: Super Poligrip Free

First Posted Date: 2021-12-30

Last Posted Date: 2024-02-16

Lead Sponsor: HALEON

Target Recruit Count: 45

Registration Number: NCT05173974

Locations: 🇺🇸
Oral Health Research Institute Indiana University School of Dentistry, Indianapolis, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy